Physician profile
Jodi L Widner
NPI 1649288481
$5,140.75
in general payments reported to CMS, 2019-2025
10 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.21 · 2022: $4,330 · 2023: $266 · 2024: $191 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777 · Travel and Lodging: $9.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.80 |
| Travel and Lodging | $9.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics Ltd | $4,435.27 | 2022-2024 | Magtrace, Magseed |
| Axogen | $347.00 | 2023-2025 | Avance Nerve Graft |
| Sientra, INC. | $118.74 | 2022 | |
| Daiichi Sankyo INC. | $113.55 | 2025 | Datroway |
| Hologic Sales and Service, LLC | $38.20 | 2025 | Magseed, Magtrace |
| Tersera Therapeutics LLC | $32.63 | 2025 | Zoladex |
| Novartis Pharmaceuticals Corporation | $23.13 | 2025 | |
| Mallinckrodt Hospital Products INC. | $17.32 | 2021 | |
| Kub Technologies INC. | $8.02 | 2024 | |
| Merit Medical Systems INC | $6.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Widner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.